Pharma & Healthcare

Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Published Dec 19, 2025

Pages 193

Report Feedback

Report a data issue, formatting problem, or request follow-up. Our team responds within one business day.

Report Overview Facts

Report ID: 1740011603
Publisher: APO Research Inc.
Published: 2025-12-19
Updated: 2026-08-08

Research methodology

Types

CRLX-101
CASI-2ME2
BC-001
Others

Applications

Solid Tumor
Colorectal Cancer
Acute Myelocytic Leukemia
Others

Key Companies

Vascular Biogenics Ltd.

Transcriptogen Ltd

Sorrento Therapeutics, Inc.

RXi Pharmaceuticals Corporation

Peloton Therapeutics, Inc.

OncoImmune, Inc.

InterMed Discovery GmbH

F. Hoffmann-La Roche Ltd.

Cerulean Pharma, Inc.

CASI Pharmaceuticals Inc.

Aileron Therapeutics, Inc.

LinkedIn X (Twitter)Facebook Email

Report Overview Facts

Report ID: 1740011603
Publisher: APO Research Inc.
Published: 2025-12-19
Updated: 2026-08-08

Research methodology

Types

CRLX-101
CASI-2ME2
BC-001
Others

Applications

Solid Tumor
Colorectal Cancer
Acute Myelocytic Leukemia
Others

Key Companies

Vascular Biogenics Ltd.

Transcriptogen Ltd

Sorrento Therapeutics, Inc.

RXi Pharmaceuticals Corporation

Peloton Therapeutics, Inc.

OncoImmune, Inc.

InterMed Discovery GmbH

F. Hoffmann-La Roche Ltd.

Cerulean Pharma, Inc.

CASI Pharmaceuticals Inc.

Aileron Therapeutics, Inc.

LinkedIn X (Twitter)Facebook Email

Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report Feedback

Report Overview Facts

Types

Applications

Key Companies

Customer Reviews

Report Overview Facts

Types

Applications

Key Companies